Hi @rafal,
This year i received Creotech Quantum stocks due to spin-off. I have sold some of them with profit, but Capitally shows that I’m in loss. I have used Spin-off transaction type and it seems that calculations do not take it into consideration properly.
In case of a spin-off, if you provide the cost-basis price, the transaction value is Price × Target Quantity, not derived from the source’s average cost. The price field there is the per-share cost basis of the received shares: that amount becomes the new position’s cost basis and is deducted from the source position’s basis as a return of capital.
One thing to check in your entry: you’ve entered 663, which is CRI’s market price. That books CRQ at 3 times its value of 220 PLN taken out of CRI. For a spinoff you normally want either the % toggle with the allocation percentage published for the event (that’s the tax-correct way - how big chunk was spun off the investment), or the target’s market price of ≈220 if you want the received shares valued at market.
Once you correct that, you will see the profit. Currently that CRQ position started much too high. Look for the correct % to enter - it should be provided by the broker or the company.
Thanks for the explanation. I didn’t notice the % toggle at first.
I have set 16.6% and now it looks as below:
Making allocation percentage negative -16.6% also leads incorrect results. I’m confused 
It’s actually correct (with 16.6%).
From perspective of CRI alone, you decreased invested capital (spin-off) by realizing some of it (transferring it)
From perspective of CRQ alone, you financed this new position from the CRI - hence the invested capital (and lower return)
From overall perspective both cancel out and convert should be transparent to taxes.